proposed a “6-Step” general radiomics model to predict IDH mutation status in Glioma patients, proposing an SVM model trained on T2 + FLAIR sequences which yielded an AUC/accuracy/sensitivity/specificity of 0.873/ 0.876/ 0.875 /0.877. Here, IDH1 is linked to central nervous system cancer.